Vimizim 5mg/5ml, Konzentrat zur Herstellung einer Infusionslösung

7680653700019 CH-65370 Konzentrat
Vimizim 5mg/5ml, Konzentrat zur Herstellung einer Infusionslösung
Vimizim 5mg/5ml, Konzentrat zur Herstellung einer Infusionslösung
Vimizim 5mg/5ml, Konzentrat zur Herstellung einer Infusionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Konzentrat
Galenic group
Tinkturen/Desinfektion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
04/02/2020
Summary of Product Characteristics
Français
04/02/2020
Summary of Product Characteristics
Italien
04/02/2020

Detailed composition

Substance Quantity Type Category
(N/A)
5.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
100.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
8.0 MG Substance HBESI

Authorization holder

DRAC AG

3280 Murten

Authorization information

Swissmedic authorization number
65370
Drug name
Vimizim, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOPA
ATC Code
A16AB12
Authorization status
Z
Dispensing category
B
First authorization
19/01/2016
Authorization expiration date
31/12/9999
IT Number
07.14.0.
Domain
Human medicine
Field of application
Behandlung der Mucopolysaccharidose Typ IVA

Package details

Description (FR)
VIMIZIM conc perf 5 mg/5ml flac
Description (DE)
VIMIZIM Inf Konz 5 mg/5ml Durchstf
Market launch
19/01/2016
Narcotic (BTM)
No